CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Iberdomide

Phase 2
Roche Holding AG (RHHBY)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
RHHBYPDUFA
Phase 2Positive

FDA PDUFA Date Iberdomide (priority review)

Iberdomide
Aug 2026~
Source
Drug Information

Target Indication

Multiple Myeloma

Clinical Trial

NCT05583617

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.